Polyrizon Ltd. (PLRZ )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PLRZ
- Company Polyrizon Ltd.
- Price $11.03
- Changes Percentage -1.78
- Change -0.2
- Day Low $10.5
- Day High $11.36
- Year High $18.2
- Year Low $2.88
- Market Cap $11,538,163
- Price Avg 50 EMA (D) $12.34
- Price Avg 200 EMA (D) $12.11
- Exchange NASDAQ
- Volume 20,938
- Average Volume 53,208
- Open $11.19
- Previous Close $11.23
- EPS -1.96
- PE -5.26
- Earnings Announcement 2026-07-01 04:00:00
- Shares Outstanding $1,120,210
Company brief: POLYRIZON LTD. (PLRZ )
- Healthcare
- Biotechnology
- Mr. Tomer Izraeli
- https://www.polyrizon-biotech.com
- IL
- N/A
- 10-29-2024
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.